Court Rules Mylan Infringes J&J Duragesic Patent
Mylan said it plans to appeal the decision and bring its generic version to market this summer, but J&J said it believes it should retain U.S. exclusivity over Duragesic until January 2005.
"Although we are disappointed with the court's ruling," Mylan vice chairman and chief executive Robert Coury said, "we intend to file an appeal."
The product in question is...
To view the full article, register now.